Seeking Alpha

Bioplayer1

Bioplayer1
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Ahead Of The Curve: Amarin To Release Better Than Expected Combo/Statin Data [View instapost]
    Steve,

    With the Phase I endpoints of AMR102 met, we now know the combo to be Crestor. I think we also have a recent patent receiving NOA. Could you clarify how Amarin intents to utilize this product given AZN's recent purchase of Epanova? Obviously AZN has the marketing muscle to defend Crestor when it goes generic in 2016.
    Jun 23, 2013. 06:13 PM | Likes Like |Link to Comment
COMMENTS STATS
1 Comment
0 Likes